Induction of adult T-cell leukemia-like lymphoproliferative disease and its inhibition by adoptive immunotherapy in T-cell-deficient nude rats inoculated with syngeneic human T-cell leukemia virus type 1-immortalized cells

被引:34
作者
Ohashi, T
Hanabuchi, S
Kato, H
Koya, Y
Takemura, F
Hirokawa, K
Yoshiki, T
Tanaka, Y
Fujii, M
Kannagi, M
机构
[1] Tokyo Med & Dent Univ, Dept Immunotherapeut, Div Med Res, Bunkyo Ku, Tokyo 113, Japan
[2] Univ Tokyo, Fac Agr, Dept Vet Internal Med, Tokyo 113, Japan
[3] Japan Sci & Technol Corp, CREST, Saitama 332, Japan
[4] Hokkaido Univ, Sch Med, Dept Pathol, Sapporo, Hokkaido 060, Japan
[5] Kitasato Univ, Sch Med, Dept Biosci, Sagamihara, Kanagawa 228, Japan
[6] Niigata Univ, Sch Med, Dept Virol, Niigata 951, Japan
关键词
D O I
10.1128/JVI.73.7.6031-6040.1999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human T-cell leukemia virus type 1 (HTLV-1) has been shown to be the etiologic agent of adult T-cell leukemia (ATL), but the in vivo mechanism by which the virus causes the malignant transformation is largely unknown. In order to investigate the mechanisms of HTLV-1 leukemogenesis, we developed a rat model system in which ATL-like disease was reproducibly observed, following inoculation of various rat HTLV-1-immortalized cell lines. When previously established cell lines, F344-S1 and TARS-1, but not TART-1 or W7TM-1, were inoculated, systemic multiple tumor development was observed in adult nude (nu/nu) rats. FPM1 cells, newly established from a heterozygous (nu/+) rat syngeneic to nu/nu rats, caused transient tumors only at the injection site in adult nu/nu rats, but could progressively grow in newborn nu/nu rats and metastasize in lymph nodes. The derivative cell line (FPM1-V1AX) serially passed through newborn nu/nu rats acquired the potency to grow in adult nu/nu rats. These results indicated that only some with additional changes but not all of the in vitro HTLV-1-immortalized cell lines possessed in vivo tumorigenicity. Using the syngeneic system, we further showed the inhibition of tumor development by transferring splenic T cells from immunized rats, suggesting the involvement of T cells in the regression of tumors. This novel and reproducible nude rat model of human ATL would be useful for investigation of leukemogenesis and antitumor immune responses in HTLV-1 infection.
引用
收藏
页码:6031 / 6040
页数:10
相关论文
共 50 条
[31]  
NISHIOKA K, 1989, LANCET, V1, P441
[32]   PHENOTYPIC PROGRESSION OF A RAT LYMPHOID-CELL LINE IMMORTALIZED BY HUMAN T-LYMPHOTROPIC VIRUS TYPE-I TO INDUCE LYMPHOMA LEUKEMIA-LIKE DISEASE IN RATS [J].
OKA, T ;
SONOBE, H ;
IWATA, J ;
KUBONISHI, I ;
SATOH, H ;
TAKATA, M ;
TANAKA, Y ;
TATENO, M ;
TOZAWA, H ;
MORI, S ;
YOSHIKI, T ;
OHTSUKI, Y .
JOURNAL OF VIROLOGY, 1992, 66 (11) :6686-6694
[33]  
OSAME M, 1986, LANCET, V1, P1031
[34]   ACTIVATED, HTLV-1-SPECIFIC CYTOTOXIC LYMPHOCYTES-T ARE FOUND IN HEALTHY SEROPOSITIVES AS WELL AS IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS [J].
PARKER, CE ;
DAENKE, S ;
NIGHTINGALE, S ;
BANGHAM, CRM .
VIROLOGY, 1992, 188 (02) :628-636
[35]   DETECTION AND ISOLATION OF TYPE-C RETROVIRUS PARTICLES FROM FRESH AND CULTURED LYMPHOCYTES OF A PATIENT WITH CUTANEOUS T-CELL LYMPHOMA [J].
POIESZ, BJ ;
RUSCETTI, FW ;
GAZDAR, AF ;
BUNN, PA ;
MINNA, JD ;
GALLO, RC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (12) :7415-7419
[36]  
SAKASHITA A, 1992, BLOOD, V79, P477
[37]  
Simpson RM, 1996, LAB INVEST, V74, P696
[38]  
TAGUCHI H, 1993, LAB INVEST, V69, P336
[39]  
TAKEMOTO S, 1994, BLOOD, V84, P3080
[40]   ONCOGENIC TRANSFORMATION BY THE TAX GENE OF HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I INVITRO [J].
TANAKA, A ;
TAKAHASHI, C ;
YAMAOKA, S ;
NOSAKA, T ;
MAKI, M ;
HATANAKA, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (03) :1071-1075